Jeremie Estepp - Publications

Affiliations: 
University of Memphis, Memphis, TN, United States 

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang W, Brown C, McNaull M, Rogers ZR, Barton M, Dua M, Hankins JS, Gossett JM, Richardson J, Porter JS, Kang G, Estepp J. Intensive hydroxyurea dosing in very young children with sickle cell anemia. Blood Advances. PMID 37695741 DOI: 10.1182/bloodadvances.2022009613  0.615
2022 Heitzer AM, Schreiber JE, Yuan X, Wang F, Pan H, Graff JC, Murphy L, Rupff R, Russell K, Wang W, Estepp JH, Hankins JS, Porter JS, Jacola LM. Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controls. British Journal of Haematology. PMID 36264030 DOI: 10.1111/bjh.18507  0.529
2022 Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G, Hankins JS. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia. Current Research in Translational Medicine. 70: 103335. PMID 35303690 DOI: 10.1016/j.retram.2022.103335  0.486
2021 Heitzer AM, Cohen DL, Okhomina VI, Trpchevska A, Potter B, Longoria J, Porter JS, Estepp JH, King A, Henley M, Kang G, Hankins JS. Neurocognitive functioning in preschool children with sickle cell disease. Pediatric Blood & Cancer. e29531. PMID 34971013 DOI: 10.1002/pbc.29531  0.618
2021 Champlin G, Hwang SN, Heitzer A, Ding J, Jacola L, Estepp JH, Wang W, Ataga KI, Owens CL, Newman J, King AA, Davis R, Kang G, Hankins JS. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia. Experimental Biology and Medicine (Maywood, N.J.). 15353702211035778. PMID 34407676 DOI: 10.1177/15353702211035778  0.513
2021 Wang W, Freeman M, Hamilton L, Carroll Y, Kang G, Moen J, Smeltzer MP, Schreiber J, Heitzer AM, Estepp J, Aygun B. Developmental screening of three-year-old children with sickle cell disease compared to controls. British Journal of Haematology. PMID 34396511 DOI: 10.1111/bjh.17780  0.58
2021 Rampersaud E, Kang G, Palmer LE, Rashkin SR, Wang S, Bi W, Alberts NM, Anghelescu D, Barton M, Birch K, Boulos N, Brandow AM, Brooke RJ, Chang TC, Chen W, ... ... Estepp JH, et al. A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease. Blood Advances. 5: 2839-2851. PMID 34283174 DOI: 10.1182/bloodadvances.2021004634  0.546
2021 Rashkin SR, Rampersaud E, Kang G, Ataga KI, Hankins JS, Wang W, Estepp JH, Weiss MJ, Lebensburger J, Zahr RS. Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results. British Journal of Haematology. PMID 34137022 DOI: 10.1111/bjh.17647  0.582
2021 Estepp JH, Cong Z, Agodoa I, Kang G, Ding J, McCarville MB, Hankins JS, Wang WC. What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study. British Journal of Haematology. 194: 463-468. PMID 34131902 DOI: 10.1111/bjh.17620  0.547
2020 Mathias JG, Nolan VG, Meadows-Taylor M, Robinson LA, Howell KE, Gurney JG, Hankins JS, Wang WC, Estepp JH, Smeltzer MP. A meta-analysis of toxicities related to hydroxycarbamide dosing strategies. Ejhaem. 1: 235-238. PMID 35847723 DOI: 10.1002/jha2.7  0.675
2020 Sapkota Y, Qin N, Ehrhardt MJ, Wang Z, Chen Y, Wilson CL, Estepp J, Rai P, Hankins JS, Burridge PW, Jefferies JL, Zhang J, Hudson MM, Robison LL, Armstrong GT, et al. Genetic variants associated with therapy-related cardiomyopathy among childhood cancer survivors of African ancestry. Cancer Research. PMID 33288658 DOI: 10.1158/0008-5472.CAN-20-2675  0.486
2020 Alberts NM, Badawy SM, Hodges J, Estepp JH, Nwosu C, Khan H, Smeltzer MP, Homayouni R, Norell S, Klesges L, Porter JS, Hankins JS. Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach. Jmir Mhealth and Uhealth. 8: e14884. PMID 32383683 DOI: 10.2196/14884  0.629
2020 Lebensburger JD, Gossett J, Zahr R, Wang WC, Ataga KI, Estepp JH, Kang G, Hankins JS. High bias and low precision for estimated versus measured glomerular filtration rate in pediatric sickle cell anemia. Haematologica. PMID 32107332 DOI: 10.3324/haematol.2019.242156  0.487
2019 El-Gohary Y, Fleming A, Zhang H, Estepp JH, Hankins JS, Wang W, Davidoff AM, Murphy AJ. Acute Chest Syndrome After Splenectomy in Children With Sickle Cell Disease. The Journal of Surgical Research. 242: 336-341. PMID 31129243 DOI: 10.1016/j.jss.2019.04.077  0.587
2019 Zahr RS, Rampersaud E, Kang G, Weiss MJ, Wu G, Davis RL, Hankins JS, Estepp JH, Lebensburger J. Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life. Haematologica. PMID 30890594 DOI: 10.3324/Haematol.2018.212779  0.579
2018 Zahr RS, Hankins JS, Kang G, Li C, Wang WC, Lebensburger J, Estepp JH. Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia. American Journal of Hematology. PMID 30359463 DOI: 10.1002/ajh.25329  0.624
2018 Mesleh Shayeb A, Smeltzer MP, Kaste SC, Brown A, Estepp JH, Nottage KA. Vaso-occlusive crisis as a predictor of symptomatic avascular necrosis in children with sickle cell disease. Pediatric Blood & Cancer. e27435. PMID 30183122 DOI: 10.1002/pbc.27435  0.599
2018 Hankins JS, Estepp JH, Hodges JR, Villavicencio MA, Robison LL, Weiss MJ, Kang G, Schreiber JE, Porter JS, Kaste SC, Saving KL, Bryant PC, Deyo JE, Nottage KA, King AA, et al. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood. Pediatric Blood & Cancer. e27228. PMID 29797644 DOI: 10.1002/Pbc.27228  0.709
2017 Estepp JH, Smeltzer MP, Kang G, Howard SC, Reiss UM. Safe Use of Low-Molecular-weight Heparin in Pediatric Acute Lymphoblastic Leukemia and Lymphoma Around Lumbar Punctures. Journal of Pediatric Hematology/Oncology. PMID 28991127 DOI: 10.1097/MPH.0000000000000988  0.583
2017 Estepp JH, Smeltzer MP, Kang G, Li C, Wang WC, Abrams C, Aygun B, Ware RE, Nottage K, Hankins JS. A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy. American Journal of Hematology. PMID 28913922 DOI: 10.1002/ajh.24906  0.722
2017 Estepp JH, Wiczling P, Moen J, Kang G, Mack JM, Liem R, Panepinto JA, Garg U, Kearns G, Neville KA. Hydroxycarbamide in Children with Sickle Cell Anemia After First-dose Vs. Chronic Therapy: Pharmacokinetics and Predictive Models for Drug Exposure. British Journal of Clinical Pharmacology. PMID 28884840 DOI: 10.1111/bcp.13426  0.321
2017 Cancio MI, Aygun B, Chui DHK, Rothman JA, Scott JP, Estepp JH, Hankins JS. The clinical severity of hemoglobin S/Black ((A) γδβ)(0) -thalassemia. Pediatric Blood & Cancer. PMID 28453928 DOI: 10.1002/pbc.26596  0.52
2016 Gammal RS, Crews KR, Haidar CE, Hoffman JM, Baker DK, Barker PJ, Estepp JH, Pei D, Broeckel U, Wang W, Weiss MJ, Relling MV, Hankins J. Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease. Pediatrics. PMID 27335380 DOI: 10.1542/Peds.2015-3479  0.531
2015 Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, et al. Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. Journal of Clinical Pharmacology. PMID 26201504 DOI: 10.1002/Jcph.598  0.344
2014 Estepp JH, Winter B, Johnson M, Smeltzer MP, Howard SC, Hankins JS. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia. Pediatric Blood & Cancer. 61: 2031-6. PMID 25132074 DOI: 10.1002/pbc.25177  0.698
2013 Estepp JH, Smeltzer MP, Wang WC, Hoehn ME, Hankins JS, Aygun B. Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children. British Journal of Haematology. 161: 402-5. PMID 23384083 DOI: 10.1111/bjh.12238  0.7
2012 Estepp JH, Smeltzer M, Reiss UM. The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children Pediatric Blood and Cancer. 59: 105-109. PMID 22106013 DOI: 10.1002/pbc.23396  0.585
Show low-probability matches.